Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma
DELCATH SYSTEMS (NASDAQ: DCTH) Delayed: 16.48 --0 (-0%)
Previous Close $16.48    52 Week High $4.72 
Open $16.32    52 Week Low $0.22 
Day High $16.49    P/E N/A 
Day Low $16.25    EPS $-102.40 
Volume 180,916